These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 29725371)
21. Correlation analysis of myonectin levels with metabolic and hormonal disorders in patients with polycystic ovary syndrome. Zhang J; Chen L; Ye J Ann Palliat Med; 2021 Mar; 10(3):3404-3409. PubMed ID: 33752430 [TBL] [Abstract][Full Text] [Related]
22. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
23. Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients. Shi W; Zhao Q; Zhao X; Xing C; He B Diabetes Metab Syndr Obes; 2021; 14():4275-4281. PubMed ID: 34703260 [TBL] [Abstract][Full Text] [Related]
24. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
25. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome. Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855 [TBL] [Abstract][Full Text] [Related]
26. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome. Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502 [TBL] [Abstract][Full Text] [Related]
27. [Plasma metastin in adolescent polycystic ovary syndrome.]. Chen XL; Mo YQ; Li L; Chen YX; Li Y; Zhang QX; Yang DZ Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):745-9. PubMed ID: 20078960 [TBL] [Abstract][Full Text] [Related]
28. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560 [TBL] [Abstract][Full Text] [Related]
29. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
30. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome. Deswal R; Nanda S; Dang AS Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034 [TBL] [Abstract][Full Text] [Related]
31. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome? Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068 [TBL] [Abstract][Full Text] [Related]
32. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977 [TBL] [Abstract][Full Text] [Related]
33. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters. Franik G; Bizoń A; Włoch S; Pluta D; Blukacz Ł; Milnerowicz H; Madej P Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4755-4761. PubMed ID: 29164590 [TBL] [Abstract][Full Text] [Related]
34. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women. Sanke S; Chander R; Jain A; Garg T; Yadav P JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785 [TBL] [Abstract][Full Text] [Related]
35. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus. Zhang Z; Wang J; Wang H Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of carotid artery elasticity and its influencing factors in non-obese PCOS patients using a technique for quantitative vascular elasticity measurement. Hu Y; Chen B; Pan Y; Xing K; Xiao Z; Sheng B; Li J; Dong H; Lv F Front Endocrinol (Lausanne); 2024; 15():1374718. PubMed ID: 39314523 [TBL] [Abstract][Full Text] [Related]
37. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948 [TBL] [Abstract][Full Text] [Related]
38. The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated? Gong W; Bilixzi A; Wang X; Lu Y; Wan L; Han L BMC Womens Health; 2021 Mar; 21(1):104. PubMed ID: 33706732 [TBL] [Abstract][Full Text] [Related]
39. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS). Atiomo WU; Fox R; Condon JE; Shaw S; Friend J; Prentice AG; Wilkin TJ Clin Endocrinol (Oxf); 2000 Apr; 52(4):487-92. PubMed ID: 10762292 [TBL] [Abstract][Full Text] [Related]
40. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. Yue CY; Lu LK; Li M; Zhang QL; Ying CM PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]